Creating Waves of Awareness
Low Priced Cancer Drugs By CIPLA
An Indian firm manufacturing cancer medication has brought down its prices to an "affordable" level. CIPLA the manufacturing firms chairman Yusuf Hamid speaks.
Cipla History | July 4, 1939 was a red-letter day for Cipla, when the Father of the Nation, Mahatma Gandhi, honoured the factory with a visit. He was "delighted to visit this Indian enterprise", he noted later. From the time Cipla came to the aid of the nation gasping for essential medicines during the Second World War, the company has been among the leaders in the pharmaceutical industry in India.
Replies to This Discussion
-
Permalink Reply by Debby Bruck on -
Breaking the Drug Monopoly.
Can you imagine if the general population could access expensive cancer drugs at a minimal price of just a dollar a day? Many questions play in my mind. - Do you think that more people would be more likely to use them?
- What other effects could this have on the marketplace and on the search for alternatives to cancer cures? We see in America especially senior citizens those in search of cheaper drugs for their diabetes, high blood pressure, cholesterol and other diseases traveling across the border to Canada to obtain medicines.
- How would this relate to those living in India?
For people with the mentality that drugs answer all medical problems, this solution will work for them. It so happens that Hamied, chairman of generic drugs giant Cipla, India’s fourth largest pharmaceutical company plans to slash the cost of three medicines to fight brain, kidney and lung cancer in India.
What benefit does this pharmaceutical mogul gain by selling inexpensive drugs throughout the African continent where AIDS spreads rampantly?
Of course, we do believe, trust and most agree the humanitarian and philanthropic motive drives this action. And, perhaps the motivation to halt big pharma monopolies and drive the prices down so that the common man could afford treatments.
A major outcome medical researches, scientists, physicians and governments could realize over a decade of a wider distribution of all these drugs concerns data. If those who take these 'life-saving' drugs document their experiences, side-effects, and positive and negative results provide an accumulated data record, we will find out whether they live up to their promises.
Sometimes, researchers cut clinical trials short, either because they feel it unethical to withhold drugs from people in need of their healing power; while other times the detrimental side-results do this.
What do other people think will happen when generic cancer drugs, available at very low cost, hit the market?
-
Permalink Reply by Dr. Wequar Ali Khan on -
Your comment on the news is appreciated. India is already using these, will the western countries import them for their citizen? It will not be easy as pharmaceutical giants will be already scratching their heads to somehow circumvent the issue;Time will answer this.
© 2013 Created by Debby Bruck.
